Answer
Yes when clinically appropriate, although the immune response may be weaker. Eligibility and timing should be reviewed by the GP or specialist responsible for the immune-suppressing condition or treatment.
Sources for this answer
- Spikevax JN.1 0.1 mg/mL dispersion for injectionemc · SmPC Current selected SmPC · Version 4
- NHSNHS · NHS medicine guidance